IMMUNOMIC THERAPEUTICS
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Nov 2030: the §8 declaration of use).
Record
- Serial number
- 98239790
- Registration number
- 7574424
- Mark type
- Word mark
- Filed
- 25 Oct 2023
- Registered
- 19 Nov 2024
- Next maintenance filing
- §8 declaration of use, due by 19 Nov 2030 (grace period to 19 May 2031)
- Attorney of record
- Christopher J. Nichols
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceutical preparations, biotechnology, and therapeutics
Owner
- Immunomic Therapeutics, Inc., Rockville, MD, US
- Immunomic Therapeutics, Inc., Rockville, MD, US
Prosecution history
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 04 Oct 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 02 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jul 2024 — NON-FINAL ACTION E-MAILED
- 17 Jul 2024 — NON-FINAL ACTION WRITTEN
- 26 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jun 2024 — NON-FINAL ACTION E-MAILED
- 14 Jun 2024 — NON-FINAL ACTION WRITTEN